Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Early ADC Changes Following Treatment with Doxorubicin Containing Anti-HER2 Immunoliposomes Predict Tumor Growth Inhibition

Evaluating Dose Timing Effects of Gefitinib (An EGFR Inhibitor) in a Breast Cancer Model Using ADC and T1

Segmentation of Tumor Necrosis by Mapping Fractional Plasma Volume (fPV) from Dynamic Albumin-(Gd-DTPA)30 Enhanced MRI for Evaluation of Therapeutic Response to Gefitinib in Breast Cancer Model